2517
The risk of cardiac decompensation in infants with supraventricular tachycardia and congestive cardiac failure should be kept in mind prior to administration of verapamil.
 infants with supraventricular tachycardia and congestive cardiac failure: Subject; congestive cardiac failure: Subject.Disorder; infants: Subject.Age; cardiac decompensation: Effect; verapamil: Treatment; verapamil: Treatment.Drug; supraventricular tachycardia: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 infants with supraventricular tachycardia and congestive cardiac failure: Subject; congestive cardiac failure: Subject.Disorder; infants: Subject.Age; cardiac decompensation: Effect; verapamil: Treatment; verapamil: Treatment.Drug; supraventricular tachycardia: Treatment.Disorder